Prot#PL101-HD301: Prilenia Therapeutics / A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Arm, Multicenter Study Evaluating the Efficacy and Safety of Pridopidine in Patients with Early Stage of Huntington Disease (PROOF-HD)

Project: Research project

Project Details

StatusFinished
Effective start/end date11/24/20 → 11/24/24

Funding

  • HSG Clinical Research, Inc. (Prot#PL101-HD301 // Prot#PL101-HD301)
  • Prilenia Neurotherapeutics Ltd (Prot#PL101-HD301 // Prot#PL101-HD301)